BNTC
$0.25
Benitec Biopharma Ltd ADR
$.00
(.40%)
BNTC
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Aug 14
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BNTC reports earnings?
Beat
Meet
Miss

Where is BNTC's stock price going from here?
Up
Flat
Down
Stock chart of BNTC
Analysts
Summary of analysts' recommendations for BNTC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.